Global Gastrointestinal Electrocardiograph Market Key Trends & Industry Forecast 2015 - 2023

Gastrointestinal diseases are mild to chronic disorders related to gastrointestinal tract (GIT), which includes diseases related to esophagus, stomach, intestines, liver, pancreas and other associated body organs. Gastrointestinal diseases may or may not be life-threatening. Gastrointestinal disorders are usually chronic in nature and cause severe inflammation and irritation of bowel. 

A large number of diagnostic tests and tools are used in the diagnosis of gastrointestinal diseases. These techniques mainly include endoscopy, electrogastrograph (EGG), MRI scanning and CT scans. Gastrointestinal electrocardiograph, also known as electrogastrograph (EGG) is a technique to measure action potentials of the stomach. The main aim of measuring action potential of stomach is to evaluate gastric motility and to determine the relation between EGG and identify the diseases related to stomach and GIT. The physiological basis of EGG underlies the motility of GI tract. The motility of GI tract is based on contractions of smooth muscle, which in turn is based on two patterns of electrical activity, namely; action potential and slow waves. Slow waves in GIT are initiated by the interstitial cells of Cajal (ICC). The maximum frequency of muscle contraction ranges from 3 waves in a minute (stomach) to 17 waves per minute (rectum). 

Obtain Report Details @
http://www.transparencymarketresearch.com/gastrointestinal-electrocardiograph-market.html

The market of gastrointestinal electrocardiograph is segmented on the basis of types of EGG, such as electrogastroenterography (EGEG) and cutaneous electrogastrography. Further, the market is also segmented on the basis of applications (gastric diseases diagnosis), such as gastric cancer diagnosis, irritable bowel syndrome, functional dyspepsia, peptic ulcer, motility disorders (vomiting, nausea, delayed gastric emptying) and others. Moreover, the market is segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). Currently, the North American region is the most lucrative market, owing to large number of patients diagnosed with gastrointestinal diseases and increased demand for advanced diagnostic technologies. However, Asia-Pacific is considered as the most promising market during the forecast period from 2014 to 2020, owing to rising prevalence of disease and increasing awareness about the GIT diseases, its symptoms, diagnostic tests and treatment.

The global market for gastrointestinal electrocardiograph is anticipated to witness a steady growth during the forecast period from 2014 to 2020. This growth is likely to support by the factors such as high prevalence of gastric disorders, increased use of advanced diagnostic technologies and growing medical infrastructure and healthcare expenditure. Large prevalence of chronic gastrointestinal diseases is another important propeller of the market growth. According to a report of National Digestive Diseases Information Clearinghouse (NDDIC), in the U.S., around 70 million people were affected by various types of digestive diseases in 2010. The report further states that around 245,000 people were killed in 2009, due to gastrointestinal diseases. Thus, high prevalence of chronic gastric diseases accelerates the market growth. Furthermore, according to the statistics provided by the Office for National Statistics, Government of the U.K., the healthcare expenditure of the U.K. has expanded from USD 101.8 billion in 2000 to USD 233.4 billion in 2012. This exponential growth in the healthcare expenditure of the developed countries (the U.S., the U.K. and Japan) propells strong development of medical infrastructure, which ultimately supports the growth of gastrointestinal electrocardiograph market. On the other hand, high cost and lack of awareness are the key restraints that may limit the market growth to some extent.

Some of the major players operating in this market include Synectics Medical, 3CPM Company, and Gastroscan amongst others.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6865

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Patient Warming Devices Market to Reach US$2.78 bn by the end of 2024

Global Patient Warming Devices Market: Overview 

This report on the patient warming devices market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various patient warming devices such as surface warming devices as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global market with respect to the leading market segments based on major products, applications and geographies. 

Obtain Report Details @
http://www.transparencymarketresearch.com/patient-warming-devices-market.html

Global Patient Warming Devices Market: Key Segments 

The global patient warming devices market has been studied based on major product/device segments, application segments, and their regional as well as national markets. Based on product type, the global market has been categorized into three major segments: surface warming systems, intravascular warming systems, and patient warming accessories. Based on applications, the market has been categorized into four major segments: acute care, perioperative care, new born care, and others. Based on end user, the market has been categorized into four major segments: hospitals, clinics, nursing facilities and others. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year. 

Global Patient Warming Devices Market: Scope of the Report 

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the patient warming devices market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter’s five forces analysis is also provided in this section to understand the market considering the different parameters that have an impact on the sustainability of the companies operating in the market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market. 

Global Patient Warming Devices Market: Regional Outlook 

Geographically, the global market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for patient warming devices has been further categorized into major national markets such as the U.S, Canada, Germany, France, the U.K., Japan, China, India and Brazil. Market revenue in terms of USD million for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year. 

Companies Mentioned in the Report 

The recommendations section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global market. The report also profiles major players in the patient warming devices market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. The key players operating in the global market are 3M Health Care, ZOLL Medical Corporation, C. R. Bard, Inc., Smiths Medical, Stryker Corporation, Medtronic plc, GE Healthcare, Inspiration Healthcare (INDITHERM), and Philips Healthcare among others. 

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7877

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Hypertrophic Cardiomyopathy Therapeutics Market Global Industry Volume By Region 2015 - 2023

The rising prevalence of chronic cardiovascular ailments has spurred the demand for effective therapeutics, thereby driving the global hypertrophic cardiomyopathy (HCM) therapeutics market. In a report titled “Hypertrophic Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023,” Transparency Market Research studies in detail the various factors fueling and challenging the global market. 

Obtain Report Details @
http://www.transparencymarketresearch.com/hypertrophic-cardiomyopathy-therapeutics-market.html
 
According to the American Heart Association, hypertrophic cardiomyopathy is a common condition that occurs when the muscle cells of the heart enlarge, causing the ventricle walls to thicken. HCM affects both men and women and is a common cause of sudden cardiac arrest in young people. The rising incidence of obstructive and non-obstructive hypertrophic cardiomyopathy is anticipated help the global market maintain a steady, albeit meager CAGR of 1.4% from 2015 to 2023. In 2014, the value of the hypertrophic cardiomyopathy therapeutics market was pegged at US$1.2 bn, which is forecast to increase to US$1.4 bn by 2023.

The global market for hypertrophic cardiomyopathy therapeutics has been studied on two fronts: By drug class and by geography.

Based on drug class, the hypertrophic cardiomyopathy therapeutics market has been categorized into calcium channel blockers, anticoagulants, beta adrenergic blocking agents, and antiarrhythmic agents. Although beta adrenergic blocking agents are the first preference for the treatment of obstructive as well as non-obstructive hypertrophic cardiomyopathy, calcium channel blockers form the largest segment in the overall market in terms of revenue. This can be attributed to the fact that the price of the latter blocking agents is much higher than that of the former.

By geography, the global hypertrophic cardiomyopathy therapeutics market comprises, Asia Pacific, North America, Europe, and Rest of the World. North America and Europe dominate the worldwide market, with the U.S. being the largest market for hypertrophic cardiomyopathy therapeutics. Accounting for a share of over 30% in 2014, the country is projected to retain is lead position throughout the forecast period. The hypertrophic cardiomyopathy therapeutics markets in Europe and North America are fueled by the rising prevalence of sedentary lifestyle among the younger population, the availability of modern healthcare infrastructure, and an increased presence of obesity. Growing awareness about hypertrophic cardiomyopathy and the various therapeutics available today has also significantly propelled the hypertrophic cardiomyopathy therapeutics market in these two regions.

Asia Pacific is predicted to be the fastest expanding market by 2023, fueled primarily by the rapid development in healthcare infrastructure, the increasing prevalence of various chronic diseases, and the growing awareness about various cardiac complications.

The report offers a detailed section on the competitive landscape of the global hypertrophic cardiomyopathy therapeutics market. The strengths, weaknesses, opportunities, and threats of each of the profiled players have also been examined in the report. Some of the promising companies in the hypertrophic cardiomyopathy therapeutics market are Teva Pharmaceuticals Limited, Gilead Sciences, Inc., Merck & Co., Inc., AstraZeneca plc, Concordia Healthcare Corp., Pfizer, Inc., Mylan N.V., Novartis AG, and Sanofi S.A.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7553

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Fragment-based Drug Discovery Market Analysis, Trends and Forecast by 2015 - 2023

Fragment-based Drug Discovery Market: Snapshot

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Combinational chemistry and high-throughput screening are some of the more recently introduced practices that have helped make fragment-based drug discovery programs a lot faster and cheaper than before. 

Additionally, as the usage of fragment-based drug discovery grows in the field of discovering weaker inhibitors, biophysical techniques become extremely useful. These techniques can be used to measure binding within fragment compounds that possess low affinity for binding.

The demand for fragment-based drug discovery, however, is expected to be greatly hindered by the lowered potency of fragment screening, the most popular component, in certain compounds. The drugs generated have a lower than required potency, thus deterring several end users from approaching this technique.

The collective impact of all such drivers and restraints can be seen on the global fragment-based drug discovery market, which is expected to expand at a CAGR of 14.4% from 2015 to 2023 by revenue. By the end of 2016, this revenue is expected to reach US$435.6 mn and US$1.15 bn by the end of 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/fragment-based-drug-discovery-market.html

North America Expected to Continue Leading Demand for Fragment-based Drug Discovery Programs

By the end of 2023, the market value of fragment-based drug discovery techniques in North America is expected to be 45.4% of the global market. While this is a drop in market value from its 2014 statistic, North America will still enjoy being a leading geographical segment for advancements in fragment-based drug discovery techniques.

The key factors responsible for the leading role of North America in fragment-based drug discovery programs is the high rate of research and development efforts undertaken by prominent market players in the region. The U.S. and Canada are both countries with advanced healthcare systems and infrastructures, and are often the base of advanced technological implementations, making North America the hub for the latest developments in fragment-based drug discovery.

This region is also ramping up its speed in development of fragment-based drug discovery techniques by employing outsourcing facilities from Asia Pacific. The demand for fragment-based drug discovery in Asia Pacific, on the other hand, is a lot higher than any other major region, owing to the rapid improvements in healthcare infrastructure and focus on better quality management in countries such as Japan and China.

Biopharmaceutical Companies Top the List of Fragment-based Drug Discovery Demand

Fragment-based drug discovery techniques have grown significantly in popularity in the recent years and have found a great scope of use in the biopharmaceuticals. This includes large companies, academic bodies, and CROs. These techniques have helped massively in creating chemical series that possess lead-like properties as they have improved the success rate of creation significantly over the conventional screening methods. Fragment-based drug discovery techniques have also been extremely useful in marking out chemical motifs from multiple targets.

It is a combination of all these factors that are expected to drive the use of fragment-based drug discovery in biopharmaceutical facilities to a revenue generation of US$565.2 mn by the end of 2023. The key providers of fragment-based drug discovery programs include Astex Pharmaceuticals, Charles River Laboratories International, Inc., Sygnature Discovery, Evotec A.G., and Beactica AB.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4741

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Sperm Bank Market By Analysis of Major Industry Segments 2016 - 2024

Global Sperm Bank Market: Overview and Dynamics

The global market for sperm banks has been witnessing increasing growth since the last few recent years, primarily owing to the surge in social acceptance and awareness among the general population. Rise in the number of young sperm donors, legalization of and increase in same-sex marriages, various technological advancements in the field of assistive reproduction, and strong support on the part of governments toward donor offspring and sperm donors are also projected to boost the sperm bank market. However, this market continues to be challenged by the negative mindset toward sperm donation, high cost of artificial insemination and assistive reproduction, and several government regulations in developing and underdeveloped countries.

Sperm donors can be of several types: Directed donor, client donor, anonymous donor, and known donor. Sperm banks offer a range of services such as sperm storage, genetic consultation, sperm donations, and semen analysis for a variety of end users such as pre-vasectomy patients, police officers, high-impact athletes, cancer patients, military personnel, firefighters, and transgender people.

Obtain Report Details @
http://www.transparencymarketresearch.com/sperm-bank-market.html

The report on the global sperm bank market offers clients an in-depth assessment of the emergence, popularity, need, and forecast of sperm banks across the globe. Various factors driving the demand for sperm banks, those that act as impediments to the market growth, and several policies and laws impacting sperm donation as a service have been carefully studied in the report. The research also highlights the present status of the vendor landscape, identifying the major players competing at a global level and evaluating their performance over the years.

Global Sperm Bank Market: Region-wise Outlook

The global sperm bank market has been segmented on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Considering that North America has the highest number of sperm banks with the highest number of licensed labs, this regional market for sperm banks is one of the largest in the world. Other factors such as the availability of advanced assisted reproductive technologies, higher disposable income and spending on health care, growing awareness among the general population, and high rate of miscarriages have also significantly contributed to the growth of the sperm bank market in North America.

Europe is a growing market for sperm banks given the surging demand for the same. However, the high unmet need is presently the only lucrative attraction for market players in the region, since there is a severe shortage of sperm donors as compared to the increasing demand. Countries such as the U.K. have been investing in new and innovative advertising plans to increase awareness among the male population in the country and encourage them to actively participate in sperm donation.

The sperm bank market in Asia Pacific holds immense opportunities owing to a high rate of infertility and miscarriages in the region. In China, For instance, the alarming levels of air pollution in China have caused a decrease in sperm quality, count, and motility, thereby driving the demand for sperm donors and sperm banks.

Global Sperm Bank Market: Vendor Landscape Assessment

The vendor landscape of the global sperm bank is consolidated to an extent, considering very few large players control a majority of the overall sperm bank market. New England Cryogenic Center Inc., Cryos International Sperm Bank, FairFax Cryobank, and Androcryos are currently the most prominent and dominant companies operating in the global sperm bank market. Orlando, a Florida-based Cyros International Sperm Bank, is presently one of the largest sperm banks in the world. With an additional base set up in Mumbai, India in 2008, Cryos has been approved by the U.S. Food and Drug Administration as well as the Indian Council of Medical Research. Recognizing the immense potential that the sperm bank market possesses, an increasing number of players have been undergoing continuous upgrade to withstand the competition presented by industry giants.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12173

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Process Liquid Analyzer Market Global Industry Volume and Region Analysis 2024

Global Process Liquid Analyzer Market: Overview

In the manufacturing sector, the precise measurement of liquids and gases is crucial. This report focuses on how the demand for process analyzers for liquids has changed over the years and the factors that have brought this change into effect. Process liquid analyzers may be used for measuring a wide range of dissolved ingredients, the conductivity of liquid materials, their pH levels, turbidity, or other factors that are integral to manufacturing operations.

Since these devices lend themselves to a myriad of operations, their use is not limited to a particular industry. They are a ubiquitous part of the following industries: Electronics and semiconductor, food and beverage, pharmaceuticals, metal and alloys, pulp and paper, textiles, waste water and water management, power and refineries, and oil and gas. Because of these wide-ranging uses of process liquid analyzers, their demand is projected to remain consistently high worldwide. TMR projects a positive outlook for the global process liquid analyzer market till 2024.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11678

With manufacturing operations being increasingly governed by demanding standards and specifications, using devices that offer accurate readings are a priority for manufacturers. This need will augur well for the global process liquid analyzer market in the years ahead.

The report on the global process liquid analyzers market makes use of meticulous primary and secondary research to highlight the changes that are occurring in this space. Untapped opportunities are also determined using both qualitative and quantitative analysis. A dedicated chapter on the top players in the market helps companies map the competitive landscape.

Global Process Liquid Analyzer Market: Trends, Drivers, and Restraints

The use of process liquid analyzers has seen an uptick in recent years in developing countries where industrialization is spreading fast. Moreover, larger companies acquiring niche market players to include specialized products in their portfolios is a defining trend in the global process liquid analyzer market. The launch of smart and integrated sensors is the biggest trend currently in developed countries. The adoption of intelligent sensors may take a few years in developing markets.

As the number of vendors in the global process liquid analyzer market is high, competition across the world is intense. Thus, companies that have been able to ace product differentiation have emerged as leaders. Yet, the market will have to counter forces such as a shortage of specialized process technicians and the lack of adequate professional support for maintenance projects. 

Global Process Liquid Analyzer Market: Segmentation

The global market for process analyzers for liquids can be segmented based on geographical regions, on the type of analyzer, and by application or end use. The key geographical segments of the market are: North America, Asia Pacific, Europe, and Rest of the World. North America currently represents the largest regional market for process liquid analyzers. The region, which is home to large industrial bases, will likely continue to exhibit a high demand for process liquid analyzers. Moreover, the massive manufacturing sectors in countries such as India and China will also boost sales in the global process liquid analyzers market.

Countries in Europe are expected to fare well as far as demand for process liquid analyzers is concerned. The strong performance of the pharmaceutical and allied industries can be credited for this. The report analyzes the market for process analyzers for liquids in a detailed manner to help readers uncover emergent trends and opportunities.

The market is characterized by a remarkably high number of vendors operating both locally and internationally. Top companies that have been profiled in the report include: Yokogawa Electric Corporation (Japan), Cemtrex Inc. (U.S), Emerson Electric Co. (U.S), ABB Ltd. (Switzerland), AMETEK Process Instruments (U.S.), and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Full Research Report on Process Liquid Analyzer Market:
http://www.transparencymarketresearch.com/process-liquid-analyzer-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

High Adoption of Wireless and Cosmetically Appealing Devices to Promote Uptake of Audiological Devices

The global audiological devices market is highly consolidated, with the top six players accounting for nearly 97% of the overall market share in 2011, reports Transparency Market Research (TMR) in a new study. The key players in the audiological devices market are GN ReSound Group, William Demant Holding A/S, Sonova Holding AG, Starkey Hearing Technologies, Widex A/S, and Siemens Healthcare. 

“The strong holdings of these key players overshadow the contribution by other companies and impose a high entry barrier to the new entrants,” says the author of the report. The contribution by local players and some global players such as Panasonic is very low. However, the competitive rivalry is high in the global audiological devices market with all its constituent companies vying to protect their standing.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1287

Growing Prevalence of Deafness to Present Appreciable Demand for Audiological Devices

According to the American Academy of Audiology (AAA), hearing loss is the third most reported chronic disability affecting the geriatric population. With the growth in the geriatric population worldwide, growth in the cases of sensorineural hearing damage has also been registered. This has helped the demand for audiological devices as a corrective measure, thereby promoting the growth of the global audiological devices market.

There are various factors such as injuries, and genetic factors, infectious diseases, noise pollution, occupational factors, and problems during childbirth, pregnancy, and polypharmacy that lead to hearing loss. The high prevalence of deafness is a major public health issue across the globe. To address this problem, various governments and international organizations are encouraging the use of audiological devices.

Another factor positively influencing the growth of the global audiological devices market is the introduction of cosmetically appealing hearing devices that are small in size and hidden. The growth of these types of devices can be attributed to the changing lifestyles and high purchasing power of the end-users. These factors have consequently boosted the growth of the global audiological devices market.

Social Stigma to Hamper Sales of Audiological Devices

The high cost of surgical solutions such as bone anchored hearing aids (BAHA) and cochlear implant surgery challenge the patients financially. This problem further amplifies for the uninsured patients, whose population is still low in emerging nations. The patients, thus prefer using conventional hearing aids, thereby hampering the growth rate of the audiological devices market.

The majority of the population suffering from hearing loss tends to be reluctant towards the use of hearing aids and other audiological devices due to the social stigma associated with them. This stigma is likely to negatively influence the growth of the global audiological devices market. However, increasing measures taken by governments, healthcare providers, and hearing aid manufacturers in order to increase the hearing aid awareness amongst the masses may change the mindset. These measures are likely to encourage the growth of the global audiological devices market.

Wide Product Portfolio to Help Hearing Aids Lead the Global Market

The global audiological devices market was valued at US$6.22 bn in 2011 and is anticipated to reach US$8.648 bn by 2018 at a 4.90% CAGR between 2012 and 2018.

In terms of product type, the global audiological devices market is segmented into BAHA, cochlear implants, hearing aids, and diagnostic devices. The hearing aids segment is the leading segment by value and is anticipated to lead the market until the end of 2018. This can be attributed to a wide product portfolio offered by hearing aids. The global hearing aids market was valued at US$4.65 bn in 2015 and is estimated to reach US$5.12 bn by 2018. However, the greater efficiency of cochlear implants and bone anchored hearing aids will assist them in registering positive growth rate.

By geography, Europe is the leading geographical segment by revenue and is expected to maintain its leadership through 2018. A growing incidence of hearing impairment in the region has fuelled the demand for sophisticated and wireless audiological devices. However, Asia Pacific is the most rapidly growing market owing to the improvement in the distribution network of global market players.

The information presented in this review is based on a Transparency Market Research report, titled, ‘Audiological Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018.’

Browse Full Research Report on Audiological Devices Market:
http://www.transparencymarketresearch.com/audiological-devices-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.